Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RemImazolam Besylate for ICU-sedation in Patients With Mechanical Ventilation After Oral and Maxillofacial Surgery
NCT05606315Phase 4Terminated
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Mar 2022
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of remimazolam in sedation, sponsored by Nanfang Hospital, Southern Medical University. Started Mar 2022; status: terminated.
02
Drugs
remimazolam
03
Conditions
sedation
Beyond the preview
Go deeper on NCT05606315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05606315.